Borgen P - Search Results

1

Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer.

Neuhausen S, Gilewski T, Norton L, Tran T, McGuire P, Swensen J, Hampel H, Borgen P, Brown K, Skolnick M, Shattuck-Eidens D, Jhanwar S, Goldgar D, Offit K. Neuhausen S, et al. Among authors: borgen p. Nat Genet. 1996 May;13(1):126-8. doi: 10.1038/ng0596-126. Nat Genet. 1996. PMID: 8673092

2

Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations.

Robson M, Levin D, Federici M, Satagopan J, Bogolminy F, Heerdt A, Borgen P, McCormick B, Hudis C, Norton L, Boyd J, Offit K. Robson M, et al. Among authors: borgen p. J Natl Cancer Inst. 1999 Dec 15;91(24):2112-7. doi: 10.1093/jnci/91.24.2112. J Natl Cancer Inst. 1999. PMID: 10601383

3

The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%.

Oddoux C, Struewing JP, Clayton CM, Neuhausen S, Brody LC, Kaback M, Haas B, Norton L, Borgen P, Jhanwar S, Goldgar D, Ostrer H, Offit K. Oddoux C, et al. Among authors: borgen p. Nat Genet. 1996 Oct;14(2):188-90. doi: 10.1038/ng1096-188. Nat Genet. 1996. PMID: 8841192

4

BRCA-associated breast cancer in young women.

Robson M, Gilewski T, Haas B, Levin D, Borgen P, Rajan P, Hirschaut Y, Pressman P, Rosen PP, Lesser ML, Norton L, Offit K. Robson M, et al. Among authors: borgen p. J Clin Oncol. 1998 May;16(5):1642-9. doi: 10.1200/JCO.1998.16.5.1642. J Clin Oncol. 1998. PMID: 9586873

5

Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.

Kauff ND, Mitra N, Robson ME, Hurley KE, Chuai S, Goldfrank D, Wadsworth E, Lee J, Cigler T, Borgen PI, Norton L, Barakat RR, Offit K. Kauff ND, et al. J Natl Cancer Inst. 2005 Sep 21;97(18):1382-4. doi: 10.1093/jnci/dji281. J Natl Cancer Inst. 2005. PMID: 16174860

6

Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis.

King TA, Li W, Brogi E, Yee CJ, Gemignani ML, Olvera N, Levine DA, Norton L, Robson ME, Offit K, Borgen PI, Boyd J. King TA, et al. Ann Surg Oncol. 2007 Sep;14(9):2510-8. doi: 10.1245/s10434-007-9372-1. Epub 2007 Jun 29. Ann Surg Oncol. 2007. PMID: 17597348

7

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.

Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA, Ellis NA, Boyd J, Borgen PI, Barakat RR, Norton L, Castiel M, Nafa K, Offit K. Kauff ND, et al. N Engl J Med. 2002 May 23;346(21):1609-15. doi: 10.1056/NEJMoa020119. Epub 2002 May 20. N Engl J Med. 2002. PMID: 12023992 Free article.

8

Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.

Scheuer L, Kauff N, Robson M, Kelly B, Barakat R, Satagopan J, Ellis N, Hensley M, Boyd J, Borgen P, Norton L, Offit K. Scheuer L, et al. Among authors: borgen p. J Clin Oncol. 2002 Mar 1;20(5):1260-8. doi: 10.1200/JCO.2002.20.5.1260. J Clin Oncol. 2002. PMID: 11870168

9

Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: a clinic-based series.

Robson M, Svahn T, McCormick B, Borgen P, Hudis CA, Norton L, Offit K. Robson M, et al. Among authors: borgen p. Cancer. 2005 Jan 1;103(1):44-51. doi: 10.1002/cncr.20728. Cancer. 2005. PMID: 15558796 Free article.

10

Insurance reimbursement for risk-reducing mastectomy and oophorectomy in women with BRCA1 or BRCA2 mutations.

Kauff ND, Scheuer L, Robson ME, Glogowski E, Kelly B, Barakat R, Heerdt A, Borgen PI, Davis JG, Offit K. Kauff ND, et al. Among authors: borgen pi. Genet Med. 2001 Nov-Dec;3(6):422-5. doi: 10.1097/00125817-200111000-00008. Genet Med. 2001. PMID: 11715007 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters